igf-1 lr3 cjc 1295 ipamorelin vs ipamorelin vs igf-1 lr3 Peptide Sciences CJC-1295 (No DAC), Ipamorelin 10mg (Blend) IGF-1 LR3 – Peptide Foundry

Wang and H.L

During learning phases rats were presented with two identical objects (one pair/phase)

Ghrelin Receptor (GHS-R1a) Selective Activation Ipamorelin acts as a highly selective agonist of the growth hormone secretagogue receptor (GHS-R1a), mimicking the natural hormone ghrelin without affecting other pituitary hormone secretion: Selective binding to GHS-R1a receptors without stimulating ACTH, cortisol, or prolactin release Rapid onset of growth hormone pulse generation (peak levels within 40-60 minutes) No significant effect on appetite stimulation unlike other ghrelin mimetics Preserved feedback regulation through endogenous growth hormone-releasing inhibitory mechanisms Research indicates that ipamorelin releases growth hormone with potency and efficacy similar to GHRP-6 (EC50 approximately 1.3 nmol/L) but with superior selectivity for growth hormone secretion

If you are considering ipamorelin for menopause, its worth taking a beat and assessing your symptoms individually, rather than going for a quick fix that isnt proven to work

Schedule a consultation with Evolve Anti-Aging & Wellness today to learn more about how CJC-1295 can enhance your wellness journey.